Teachers Retirement System of The State of Kentucky boosted its stake in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 0.5% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 90,199 shares of the medical research company’s stock after buying an additional 459 shares during the period. Teachers Retirement System of The State of Kentucky’s holdings in Thermo Fisher Scientific were worth $13,855,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Achmea Investment Management B.V. purchased a new position in shares of Thermo Fisher Scientific during the first quarter valued at $2,559,000. North Star Asset Management Inc. boosted its position in shares of Thermo Fisher Scientific by 4.1% in the first quarter. North Star Asset Management Inc. now owns 48,571 shares of the medical research company’s stock valued at $7,461,000 after buying an additional 1,932 shares during the last quarter. Bank of Nova Scotia boosted its position in shares of Thermo Fisher Scientific by 50.7% in the first quarter. Bank of Nova Scotia now owns 239,394 shares of the medical research company’s stock valued at $36,771,000 after buying an additional 80,519 shares during the last quarter. Summit Global Investments boosted its position in shares of Thermo Fisher Scientific by 10.0% in the first quarter. Summit Global Investments now owns 2,750 shares of the medical research company’s stock valued at $422,000 after buying an additional 250 shares during the last quarter. Finally, FNY Managed Accounts LLC purchased a new position in shares of Thermo Fisher Scientific during the first quarter valued at $153,000. 87.60% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Thermo Fisher Scientific Inc (TMO) traded up 0.38% during mid-day trading on Tuesday, reaching $174.70. 353,657 shares of the company’s stock were exchanged. Thermo Fisher Scientific Inc has a 52 week low of $139.07 and a 52 week high of $182.87. The stock has a 50 day moving average price of $176.77 and a 200 day moving average price of $166.03. The stock has a market cap of $68.15 billion, a price-to-earnings ratio of 30.44 and a beta of 1.06.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.03. The business had revenue of $5 billion for the quarter, compared to analyst estimates of $4.92 billion. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The company’s revenue was up 10.2% compared to the same quarter last year. During the same period in the previous year, the company posted $2.03 EPS. Equities research analysts predict that Thermo Fisher Scientific Inc will post $9.24 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 15th will be paid a $0.15 dividend. This represents a $0.60 annualized dividend and a dividend yield of 0.34%. The ex-dividend date is Thursday, September 14th. Thermo Fisher Scientific’s dividend payout ratio is currently 10.45%.

TRADEMARK VIOLATION WARNING: “Teachers Retirement System of The State of Kentucky Purchases 459 Shares of Thermo Fisher Scientific Inc (TMO)” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The legal version of this report can be read at https://www.thecerbatgem.com/2017/08/15/teachers-retirement-system-of-the-state-of-kentucky-purchases-459-shares-of-thermo-fisher-scientific-inc-tmo.html.

Several brokerages have recently weighed in on TMO. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $197.00 price target on the stock in a research report on Tuesday, August 1st. BidaskClub cut shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Bank of America Corporation reaffirmed a “buy” rating and issued a $210.00 target price (up previously from $200.00) on shares of Thermo Fisher Scientific in a research report on Friday, July 21st. Cleveland Research raised shares of Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a research report on Thursday, July 20th. Finally, Barclays PLC reaffirmed an “overweight” rating and issued a $200.00 target price (up previously from $190.00) on shares of Thermo Fisher Scientific in a research report on Monday, July 17th. One investment analyst has rated the stock with a hold rating, sixteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. Thermo Fisher Scientific currently has an average rating of “Buy” and a consensus price target of $188.56.

In other news, insider Daniel P. Shine sold 4,688 shares of Thermo Fisher Scientific stock in a transaction dated Wednesday, May 24th. The stock was sold at an average price of $171.88, for a total value of $805,773.44. Following the transaction, the insider now directly owns 29,200 shares of the company’s stock, valued at approximately $5,018,896. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Stephen Williamson sold 2,500 shares of Thermo Fisher Scientific stock in a transaction dated Monday, June 5th. The shares were sold at an average price of $176.26, for a total value of $440,650.00. Following the completion of the transaction, the chief financial officer now directly owns 37,790 shares in the company, valued at $6,660,865.40. The disclosure for this sale can be found here. Insiders sold a total of 27,188 shares of company stock worth $4,702,223 over the last ninety days. Corporate insiders own 0.49% of the company’s stock.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Stock Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related stocks with our FREE daily email newsletter.